Neurologists and Psychiatrists

Welcome Message

We are pleased to invite participants from around the world to the “35^th Euro Congress on Neurologists and Psychiatrists,” scheduled for August 27–28, 2026, as a global webinar. Centered on the theme “Advancing Innovations in Neurology, Psychiatry, and Brain Health,” this prestigious event will highlight the latest scientific discoveries, clinical advancements, and emerging trends shaping the future of neurological and psychiatric care.

The Euro Neuro 2026 serves as a dynamic platform to explore cutting-edge developments in neurology, psychiatry, neuroscience, neurodegenerative disorders, mental health, brain imaging, neuropharmacology, cognitive sciences, and innovative therapeutic approaches. Renowned speakers, researchers, clinicians, and healthcare professionals from across the globe will share their expertise, providing valuable insights to an international audience.

This event is designed to foster collaboration and meaningful knowledge exchange among neurologists, psychiatrists, neuroscientists, psychologists, researchers, academicians, healthcare practitioners, industry experts, and students. It offers opportunities to present research findings, discuss current challenges in neurological and mental healthcare, and explore emerging diagnostic and treatment strategies. By bringing together the global scientific community, the congress aims to strengthen professional networks, inspire innovation, and contribute to advancing brain health, mental well-being, and patient care worldwide.

About Conference

A prestigious global forum, Euro Neuro 2026 brings together neurologists, psychiatrists, neuroscientists, clinicians, researchers, academics, medical professionals, and business leaders from all around the world. Whether you are a student, a healthcare professional, an early-career researcher, or an experienced specialist, this congress offers a fantastic opportunity to learn, share, and support the continued global growth of neurological and psychiatric sciences.

The two-day virtual event, with the theme "Advancing Innovations in Neurology, Psychiatry, and Brain Health" aims to promote multidisciplinary collaboration, promote scientific exchange, and highlight the most recent developments in neurology, psychiatry, neuroscience, and mental health.

Why to attend

1. Attend motivational keynote and plenary lectures by World-Class Experts
2. Use scientific oral and poster presentations to share your research with a worldwide audience and increase your visibility
3. Take part in expert panel discussions that highlight the most recent developments, difficulties, and prospects for neurology and psychiatry.
4. Use networking and chances for interdisciplinary collaboration to create meaningful international connections.
5. Examine New Developments and Clinical Progress in Mental Health, Neuroscience, Neurotechnology, and Patient Care
6. Connect with top researchers, physicians, and healthcare professionals globally to obtain professional recognition and opportunities for career advancement.

Target Audience 

• Neurologists
• Psychiatrists
• Neuroscientists
• Clinical Psychologists
• Neuropsychiatrists
• Pediatric Neurologists
• Geriatric Psychiatrists
• Mental Health Professionals
• Neurosurgery Specialists
• Neuropharmacologists
• Cognitive Neuroscience Researchers
• Academic Researchers and Scientists
• Medical Faculty and Professors
• Physicians and General Practitioners
• Nurses and Mental Health Nurses
• Rehabilitation Specialists
• Neuroimaging Experts
• Pharmaceutical and Biotechnology Professionals
• Medical and Healthcare Students
• Healthcare Policymakers and Industry Leaders

Abstract Submission & Registration Guidelines

Researchers, clinicians, academicians, healthcare professionals, and speakers from around the world are invited to submit their abstracts, case reports, research papers, and posters related to the topics listed under the Call for Abstracts or aligned with their areas of expertise in Neurology, Psychiatry, Neuroscience, and Mental Health.

Submission Requirements:

• The abstract should be no longer than 500 words.
• Include the full names, affiliations, and designations of all authors and co-authors.
• Submit a brief biography (maximum 150 words) and a recent photograph of the presenting author.
• Abstracts may cover original research, clinical studies, case reports, innovative therapeutic approaches, neuroscience advancements, mental health research, neurological disorders, psychiatric interventions, and related disciplines.
• All submitted abstracts will undergo peer review by the Scientific Committee, and authors will receive notification regarding acceptance within 24–48 hours of submission.
• Accepted abstracts will be published in the conference proceedings and selected indexed journals.

We welcome contributions that promote scientific excellence, interdisciplinary collaboration, and advancements in neurological and psychiatric research, clinical practice, and patient care.

Submit your Abstarct here: https://euroneuro.annualcongress.com/abstract-submission.php

Registration

The 35th Euro Congress on Neurologists and Psychiatrists 2026 is a premier international platform dedicated to advancing research, clinical practice, and innovation in Neurology, Psychiatry, Neuroscience, and Mental Health. This two-day webinar aims to foster scientific collaboration, professional development, and meaningful discussions among neurologists, psychiatrists, researchers, clinicians, academicians, healthcare professionals, and industry experts from around the world.

To encourage broad participation, the congress offers flexible and affordable registration options, including special discounts for groups and institutions. Whether you are a student, researcher, academician, clinician, healthcare practitioner, or industry representative, you can conveniently register through the link below.

Register Now: https://euroneuro.annualcongress.com/registration.php

Having trouble with registration?

Please contact the Program Manager via neurology@memeetings.com The organizing team of the 35th Euro Congress on Neurologists and Psychiatrists 2026 will provide an invoice for the requested registration category, enabling participants to complete payment through a secure bank-to-bank transfer.

We look forward to welcoming you to this exceptional global gathering focused on advancing neurological and psychiatric research, innovation, and patient care.

Sessions

Track 1: AI and Digital Innovations in Neurology & Psychiatry

The transformative role of artificial intelligence, machine learning, and digital technologies in neurological and psychiatric care. Topics include AI-assisted diagnostics, predictive analytics, digital biomarkers, clinical decision support systems, and personalized treatment approaches. Participants will discover how emerging technologies are improving patient outcomes and reshaping healthcare delivery. The session also highlights ethical considerations and future innovations in brain health research. Researchers, clinicians, and technology experts are encouraged to contribute their findings.

• Machine Learning in Healthcare
• AI-Assisted Diagnostics
• Digital Biomarkers
• Predictive Analytics
• Clinical Decision Support Systems
• Healthcare Data Science

Track 2: Advances in Alzheimer's and Parkinson's Disease

Recent breakthroughs in understanding, diagnosing, and treating Alzheimer's and Parkinson's diseases. Discussions will cover disease mechanisms, biomarkers, genetics, early detection, and emerging therapies. Researchers will present advances aimed at slowing disease progression and improving patient quality of life. The session encourages multidisciplinary collaboration to address the growing global burden of neurodegenerative disorders. Novel clinical and translational research findings are highly welcomed.

• Alzheimer's Disease Research
• Parkinson's Disease Innovations
• Neurodegeneration Mechanisms
• Biomarkers in Neurodegeneration
• Novel Therapeutic Strategies

Track 3: Rare Disorders, Clinical Innovations & Diagnostic Challenges

This provides a platform for presenting rare neurological and psychiatric disorders, unusual clinical findings, and complex diagnostic cases. Participants can share innovative approaches to diagnosis, treatment, and patient management. The session aims to improve awareness and understanding of uncommon conditions that often require multidisciplinary expertise. Clinical case studies and real-world experiences are highly encouraged. It offers valuable learning opportunities for clinicians and researchers alike.

• Rare Neurological Disorders
• Rare Psychiatric Conditions
• Challenging Case Studies
• Diagnostic Innovations
• Clinical Decision-MakinG

Track 4: Translational Neuroscience and Therapeutic Innovations

Translational Neuroscience and Therapeutic Innovations  bridges laboratory discoveries and clinical applications in neuroscience. It highlights translational research that advances new therapies, diagnostic tools, and treatment strategies for neurological and psychiatric disorders. Researchers will discuss how scientific discoveries move from bench to bedside to improve patient outcomes. The track promotes collaboration between basic scientists, clinicians, and industry professionals. Emerging therapeutic technologies and interventions will be explored.

• Translational Brain Research
• Novel Therapeutics
• Drug Development
• Clinical Translation
• Experimental Medicine

Track 5: Precision Medicine in Neuropsychiatric Care

Brain-Computer Interfaces and Neurotechnology examines personalized approaches to diagnosing and treating neurological and psychiatric disorders. Topics include genomics, pharmacogenomics, biomarkers, and individualized treatment strategies. Participants will explore how precision medicine is improving healthcare outcomes through targeted interventions. The session highlights innovations that support patient-centered care and evidence-based treatment decisions. Contributions from clinical and translational researchers are encouraged.
• Precision Neurology
• Precision Psychiatry
• Genomic Medicine
• Pharmacogenomics
• Personalized Therapeutics

Track 6: Brain-Computer Interfaces and Neurotechnology

Brain-Computer Interfaces and Neurotechnology explores cutting-edge neurotechnologies that enable communication between the brain and external devices. Discussions will focus on neural interfaces, neuroprosthetics, wearable technologies, and assistive systems designed to enhance patient care and quality of life. Researchers will present advancements that are revolutionizing the understanding and treatment of neurological disorders. The session highlights innovations that bridge neuroscience, engineering, and clinical practice. Contributions from academia, healthcare, and industry are welcomed.

• Brain-Computer Interfaces
• Neural Engineering
• Neuroprosthetics
• Neural Signal Processing
• Assistive Technologies

Track 7: Digital Mental Health

The Digital Mental Health has growing role of digital platforms in mental healthcare delivery. Topics include telepsychiatry, mobile health applications, digital therapeutics, and remote patient monitoring. Participants will discuss opportunities to improve access to care while addressing ethical, clinical, and technological challenges. The track highlights innovative approaches to supporting mental well-being in the digital age. Research and practical experiences are encouraged.

• Telepsychiatry
• Digital Therapeutics
• Remote Patient Monitoring
• Virtual Care Models
• Digital Well-Being

Track 8: Neuroimaging and Advanced Diagnostics

Neuroimaging and Advanced Diagnostics focuses on modern imaging technologies and diagnostic tools used to understand brain structure and function. Sessions will explore MRI, PET, functional imaging, neurodiagnostics, and advanced analytical techniques. Researchers will present innovations that enhance disease detection and treatment planning. The track aims to improve diagnostic accuracy and patient outcomes. Contributions from clinicians and imaging specialists are invited.

• Magnetic Resonance Imaging
• Functional Neuroimaging
• PET Imaging
• Brain Mapping

Track 9: Emerging Therapeutics and Neuropharmacology

 Emerging Therapeutics and Neuropharmacology advances in pharmacological and therapeutic approaches for neurological and psychiatric disorders. Discussions will cover novel drug development, targeted therapies, treatment optimization, and clinical trials. Researchers will present innovative strategies aimed at improving efficacy and safety. The session encourages collaboration between scientists, clinicians, and pharmaceutical experts. Emerging therapeutic breakthroughs are a major focus.

• Neuropharmacology
• Drug Discovery
• Clinical Trials
• Targeted Therapies

Track 10: Anxiety, Depression, and Mood Disorders

Anxiety, Depression, and Mood Disorders explores the causes, diagnosis, and treatment of common mood and anxiety disorders. Sessions will address biological, psychological, and social factors influencing mental health outcomes. Researchers will discuss innovative therapies, prevention strategies, and patient-centered care approaches. The track aims to advance understanding and improve clinical management. Contributions from mental health professionals and researchers are welcomed.

• Anxiety Disorders
• Major Depression
• Bipolar Disorder
• Mood Regulation
• Psychological Interventions
• Mental Health Outcomes

Track 11: Cognitive Neuroscience and Brain Function

 The neural mechanisms underlying cognition, behavior, memory, learning, and decision-making. Participants will explore advances in understanding brain function and cognitive processes. Research spanning experimental, clinical, and computational neuroscience will be presented. The track promotes interdisciplinary collaboration to uncover the complexities of human cognition. Emerging discoveries in cognitive science are encouraged.

• Memory and Learning
• Cognitive Function
• Decision-Making
• Behavioral Neuroscience

Track 12: Stroke Prevention, Treatment, and Recovery

The current strategies for preventing, diagnosing, and managing stroke. Topics include acute interventions, rehabilitation techniques, risk reduction, and long-term recovery. Researchers will present innovations aimed at improving patient outcomes and quality of life. The session highlights multidisciplinary approaches to stroke care. Clinical and translational studies are encouraged.

• Stroke Prevention
• Acute Stroke Care
• Rehabilitation Strategies
• Neurovascular Disorders

Track 13: Autism and Neurodevelopmental Disorders

 Autism Neureuro development Disorders explores the diagnosis, management, and research advancements in autism spectrum and related neurodevelopmental disorders. Discussions will include genetics, early intervention, behavioral therapies, and developmental neuroscience. Researchers will examine strategies to improve outcomes across the lifespan. The session encourages multidisciplinary perspectives and innovative research. Contributions from clinicians and educators are welcomed.

• Autism Spectrum Disorders
• Developmental Neuroscience
• Early Intervention
• Genetic Factors

Track 14: Child and Adolescent Psychiatry

The Child and Adolescent Psychiatry focuses on mental health challenges affecting children and adolescents. Topics include developmental disorders, behavioral conditions, emotional well-being, and early psychiatric interventions. Researchers will present evidence-based approaches to diagnosis and treatment. The track highlights the importance of early identification and prevention. Contributions aimed at improving youth mental health are encouraged

• Pediatric Mental Health
• Adolescent Psychiatry
• Behavioral Disorders
• Emotional Development

Track 15: Sleep Disorders and Brain Health

The Sleep Disorders and Brain Health examines the relationship between sleep and neurological as well as psychiatric health. Discussions will address sleep disorders, circadian rhythms, cognitive function, and disease risk. Researchers will present advances in diagnosis, treatment, and sleep science. The session highlights the critical role of sleep in maintaining brain health. Clinical and research contributions are welcomed.

• Sleep Medicine
• Insomnia Research
• Circadian Rhythm Disorders
• Sleep and Cognition

Track 16: Neuro rehabilitation and Neurological Recovery

 Neuro rehabilitation approaches that support recovery following neurological injury or disease. Topics include physical rehabilitation, cognitive recovery, assistive technologies, and patient-centered care. Researchers will discuss innovative interventions designed to maximize functional outcomes. The session promotes multidisciplinary collaboration in rehabilitation science. Emerging therapeutic approaches are encouraged.

• Neuro rehabilitation
• Motor Recovery
• Functional Recovery
• Rehabilitation Innovation

Track 17: Neuroimmunology and Neuroinflammatory Disorders

The Neuroimmunology and Neuroinflammatory Disorders explores the role of the immune system in neurological diseases. Topics include neuroinflammation, autoimmune disorders, multiple sclerosis, and emerging immunotherapies. Researchers will discuss mechanisms driving disease progression and therapeutic innovation. The track highlights rapidly evolving discoveries in neuroimmune interactions. Contributions from both basic and clinical researchers are encouraged.

• Neuroinflammation
• Multiple Sclerosis
• Autoimmune Neurology
• Neuroimmune Mechanisms

Track 18: Biomarkers and Early Disease Detection

The identification and validation of biomarkers for neurological and psychiatric disorders. Discussions will cover molecular, genetic, imaging, and digital biomarkers that support early diagnosis and precision care. Researchers will present advances that improve disease prediction and monitoring. The session promotes innovation in personalized healthcare. Emerging biomarker research is highly encouraged.

• Molecular Biomarkers
• Genetic Biomarkers
• Imaging Biomarkers
• Digital Biomarkers

Track 19: Addiction Psychiatry and Substance Use Disorders

The Addiction Psychiatry examines the biological, psychological, and social aspects of addiction and substance use disorders. Topics include prevention, diagnosis, treatment, recovery, and public health approaches. Researchers will explore innovative interventions and evidence-based care models in Substance Use Disorder. The is to reduce the burden of addiction worldwide. Contributions from clinicians and researchers are welcomed.

• Substance Use Disorders
• Addiction Neuroscience
• Behavioral Addictions

Track 20: Gut-Brain Axis and Mental Health

The Gut- Brain Axis and Mental Health explores the complex relationship between the gut microbiome, brain function, and mental health. Topics include microbiome research, neuroimmune interactions, metabolic pathways, and psychiatric outcomes. Researchers will discuss emerging evidence linking gut health to neurological and mental disorders. The track highlights novel therapeutic opportunities and interdisciplinary collaboration. Contributions from both clinical and basic science researchers are encouraged.

• Gut Microbiome Research
• Microbiota-Brain Communication
• Neuroimmune Interactions

Market Analysis

1. Global AI in Neurology:

The global Artificial Intelligence (AI) in Neurology market is experiencing remarkable growth, driven by increasing demand for advanced diagnostic tools, predictive analytics, and personalized patient care. The market is projected to expand from USD 760 million in 2025 to approximately USD 4.5 billion by 2033, reflecting strong adoption across healthcare systems worldwide. AI-powered technologies are transforming neurological disease diagnosis, neuroimaging analysis, clinical decision-making, and treatment planning. This rapid growth highlights the expanding role of AI in improving patient outcomes and shaping the future of neurological healthcare and research.

2.Global Neurology and Psychiatry Market Forecast

The global neurology and psychiatry market is experiencing steady growth.  As illustrated in the market forecast, the industry is projected to expand significantly from USD 132.9 billion in 2024 to approximately USD 281.0 billion by 2032, reflecting strong demand for innovative diagnostic and therapeutic solutions. Advances in artificial intelligence, neuroimaging, neurotechnology, precision medicine, and digital mental health platforms are transforming patient care and accelerating research opportunities. This growth underscores the increasing importance of interdisciplinary collaboration among clinicians, researchers, healthcare providers, and industry leaders in shaping the future of brain and mental health sciences.

Past Conference

Leading neurologists, psychiatrists, neuroscientists, researchers, clinicians, academicians, and healthcare workers from all over the world came together for the successful 34th Euro Congress on Neurologists and Psychiatrists. The congress, which had as its topic "Bridging Minds, Advancing Neuroscience, Transforming Mental Health” offered a useful forum for international cooperation, creative dialogue, and scientific exchange in the domains of neurology, psychiatry, and mental health.

The conference exhibited the most recent developments in brain research and mental healthcare through keynote addresses, plenary talks, scientific presentations, expert panel discussions, and networking opportunities. We would like to express our gratitude to all of the speakers, delegates, session chairmen, poster presenters, industry partners, and members of the organizing committee.

Building on this momentum, we are excited to invite attendees to the 35th Euro Congress on Neurologists and Psychiatrists Webinar, which is set for August 27–28, 2026. There, experts from around the world will once more convene to discuss research, cutting-edge technologies, and future directions in neurology and psychiatry.